We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.74%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$20.8B
AUM Growth
+$3.81B
(+22%)
Cap. Flow
+$2.41B
Cap. Flow
% of AUM
11.56%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
2,920
New
199
Increased
391
Reduced
1,521
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$974M |
| 2 |
Amazon
AMZN
|
+$604M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 4 |
Bank of America
BAC
|
+$83.7M |
| 5 |
Advanced Micro Devices
AMD
|
+$72.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$49.7M |
| 2 |
NVIDIA
NVDA
|
+$37.1M |
| 3 |
Microsoft
MSFT
|
+$33.4M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.9M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.99% |
| 2 | Financials | 13.3% |
| 3 | Consumer Discretionary | 10.8% |
| 4 | Healthcare | 9.36% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
National Beverage
FIZZ
$2.9B
| $522K | ﹤0.01% |
14,127
| – | – |
|
1777
Community Trust Bancorp
CTBI
$1.44B
| $521K | ﹤0.01% |
9,320
| – | – |
|
|
ONT
1778
Onterris Inc
ONT
$576M
| $521K | ﹤0.01% |
18,975
-1,698
| -8% | -$44.4K |
|
1779
Bentley Systems
BSY
$11B
| $519K | ﹤0.01% |
10,078
+291
| +3% | +$15.9K |
|
1780
Univest Financial
UVSP
$1.18B
| $518K | ﹤0.01% |
17,246
| – | – |
|
1781
NETGEAR
NTGR
$658M
| $514K | ﹤0.01% |
15,879
| – | – |
|
1782
Tompkins Financial
TMP
$1.44B
| $513K | ﹤0.01% |
7,741
-694
| -8% | -$46.5K |
|
1783
Byline Bancorp
BY
$1.78B
| $512K | ﹤0.01% |
18,473
-185
| -1% | -$5.16K |
|
1784
Cable One
CABO
$191M
| $512K | ﹤0.01% |
2,893
-317
| -10% | -$47.6K |
|
1785
Old Second Bancorp
OSBC
$1.31B
| $511K | ﹤0.01% |
29,565
+4,063
| +16% | +$73.2K |
|
1786
Yext
YEXT
$613M
| $510K | ﹤0.01% |
59,884
-2,218
| -4% | -$18.8K |
|
|
UNIT
1787
Uniti Group
UNIT
$2.31B
| $509K | ﹤0.01% |
83,198
-65,960
| -44% | -$395K |
|
1788
First Mid Bancshares
FMBH
$1.38B
| $509K | ﹤0.01% |
13,439
| – | – |
|
1789
Aehr Test Systems
AEHR
$4.02B
| $503K | ﹤0.01% |
16,702
-2,066
| -11% | -$44.7K |
|
1790
Enliven Therapeutics
ELVN
$4.25B
| $503K | ﹤0.01% |
24,556
+3,345
| +16% | +$67.4K |
|
1791
AMERISAFE
AMSF
$504M
| $503K | ﹤0.01% |
11,464
| – | – |
|
1792
XPEL
XPEL
$1.35B
| $502K | ﹤0.01% |
15,169
| – | – |
|
1793
Spyre Therapeutics
SYRE
$8.98B
| $501K | ﹤0.01% |
29,918
| – | – |
|
1794
Corcept Therapeutics
CORT
$12.1B
| $500K | ﹤0.01% |
6,017
+174
| +3% | +$12.6K |
|
1795
Revolve Group
RVLV
$1.69B
| $499K | ﹤0.01% |
23,448
| – | – |
|
1796
Herbalife
HLF
$1.28B
| $498K | ﹤0.01% |
58,987
-809
| -1% | -$7.63K |
|
1797
AdaptHealth
AHCO
$760M
| $498K | ﹤0.01% |
55,615
-3,526
| -6% | -$32.7K |
|
|
TRML
1798
DELISTED
Tourmaline Bio
TRML
| $497K | ﹤0.01% |
10,394
-3,159
| -23% | -$87.6K |
|
1799
Immunome
IMNM
$3.18B
| $497K | ﹤0.01% |
42,411
| – | – |
|
|
NPKI
1800
NPK International
NPKI
$1.19B
| $496K | ﹤0.01% |
43,864
-4,528
| -9% | -$44.1K |
|
Similar funds
BA
FAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, MetLife Investment Management held 2,920 positions worth $20.8B, up 22% from $17B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
MetLife Investment Management deployed $2.41B of net new capital in Q3 2025, opening 199 new positions and adding to 391 existing holdings. Its largest new stake was Apple: 4,311,733 shares worth $1.1B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $37.1M trimmed.
- MetLife Investment Management's largest Q3 2025 buy was Apple: 4,311,733 shares worth $1.1B.
- MetLife Investment Management added most to Applovin in Q3 2025, an estimated $29.1M increase.
- MetLife Investment Management's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $37.1M.
- MetLife Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $49.7M.
- MetLife Investment Management's ten largest holdings make up 30% of its $20.8B portfolio in Q3 2025.
- MetLife Investment Management opened 199 new positions and closed 76 in Q3 2025.
- MetLife Investment Management's portfolio value rose 22% quarter-over-quarter to $20.8B.
Based on MetLife Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.